Design
Review
Authors
Loading...
Serotonin pathways in pulmonary hypertension warrant no practice change; leaves open targeted therapeutic hypotheses for prospective validation.
Key points are not available for this paper at this time.
Egermayer et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: